Similar articles

• Randomized comparison of hexamethylmelamine, adriamycin, cyclophosphamide (HAC) vs. cisplatin, adriamycin, cyclophosphamide (PAC) in advanced ovarian cancer: long-term results.

  Sessa C, Colombo N, Bolis G, Marsoni S, Mangioni C. Sessa C, et al. Cancer Treat Rev. 1991 Mar;18 Suppl A:37-46. doi: 10.1016/0305-7372(91)90023-s. Cancer Treat Rev. 1991. PMID: 1904308 Clinical Trial. No abstract available.
• The role of hexamethylmelamine in the combination chemotherapy of advanced ovarian cancer: a comparison of hexamethylmelamine, cyclophosphamide, doxorubicin, and cisplatin (H-CAP) versus cyclophosphamide, doxorubicin, and cisplatin (CAP).

  Hainsworth JD, Jones HW 3rd, Burnett LS, Johnson DH, Greco FA. Hainsworth JD, et al. Am J Clin Oncol. 1990 Oct;13(5):410-5. doi: 10.1097/00000421-199010000-00009. Am J Clin Oncol. 1990. PMID: 2121019
• [Comparative research on different treatment regimens in disseminated cancer of the ovaries].

  Marinov L, Koĭnov K, Tsekova V, Velikova M. Marinov L, et al. Akush Ginekol (Sofiia). 1987;26(1):49-52. Akush Ginekol (Sofiia). 1987. PMID: 3592111 Bulgarian. No abstract available.
• Chemotherapy of ovarian cancer.

  Ozols RF, Young RC. Ozols RF, et al. Semin Oncol. 1984 Sep;11(3):251-63. Semin Oncol. 1984. PMID: 6435250 Review. No abstract available.
• [High-dose chemotherapy in ovarian adenocarcinoma].

  Lotz JP, Lhommé C, Pautier P, Couteau C, Gligorov J, Alexandre J, Selle F, Izrael V, Maraninchi D, Viens P. Lotz JP, et al. Bull Cancer. 2000 Jan;87(1):63-9. Bull Cancer. 2000. PMID: 10673633 Review. French. No abstract available.